$IBO News

Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)

CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)

Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)

Impact BioMedical Announces 1-For-12.62 Reverse Stock Split, Reducing Shares Outstanding From ~107.8M To ~8.54M, Effective Sept. 23

Impact BioMedical Q1 EPS $(0.02) Up From $(0.11) YoY, Sales $7.000K

Reported Friday, Impact BioMedical Reports Going Concern Audit Opinion For Fiscal Year 2025 While Continuing Strategic Merger Plans With Dr. Ashley's Ltd.

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

Unusual volume stocks are being observed in Thursday's session.

Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

Impact BioMedical Q2 EPS $(1.18), Sales $7.00K

Impact BioMedical Stock Is Soaring Monday: What's Going On?

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

Impact BioMedical shares are trading higher after the company announced a limited merger and share exchange agreement with Dr Ashleys.

Impact BioMedical And Dr Ashleys Limited Announce Merger And Share Exchange Agreement; Dr. Ashleys To Acquire Impact BioMedical Through A Reverse Merger

Dr Ashleys to Go Public via Merger With Impact BioMedical in NYSE Deal

Impact BioMedical Shares Resume Trade

Impact BioMedical Shares Resume Trade Then Again Halted On Circuit Breaker To The Downside, Stock Now Down -42.4%

Impact BioMedical Shares Halted On Circuit Breaker To The Downside, Stock Now Down -30%

Impact Biomedical Inc. Announcement Stock Activity/Pricing